Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy

Hypertension is a major modifiable risk factor for cardiovascular diseases (ischaemic heart disease, stroke, heart failure and ischaemic artery disease of the lower limbs) and the most epidemiologically significant cause of death in the world. At the same time, the prevalence of hypertension in Poland is constantly increasing — according to the 2002 NATPOL study, it was 29% of adult Polish population. In the second NATPOL study, the proportion of hypertensive patients increased to 32% and in the WOBASZ II study in 2014 it reached 43%.